依达拉奉联合长春西汀治疗急性脑梗死疗效观察

The efficacy of edaravone combined with vinpocetine for ac ute cerebral infarction

目的观察依达拉奉联合长春西汀治疗急性脑梗死的临床疗效。方法将60例急性脑梗死患者随机分为联合治疗组（30例）和对照组（30例）。联合治疗组给予依达拉奉和长春西汀治疗，对照组给予长春西汀治疗。两组均给予对症基础治疗。结果两组患者的临床疗效比较，联合治疗组总有效率100％，对照组总有效率70％，联合治疗组疗效优于对照组，两组比较差异有显著性（P〈0．05）。结论依达拉奉联合长春西汀能显著提高急性脑梗死患者的临床疗效，值得临床推广应用。

Objective To observe the efficacy of edaravone combined with vinpocetine in the treatment of acute cerebral infarction. Methods 60 patients were randomly assigned to receive combination therapy with edaravone and vinpocetine （ 30 patients, study group ）, or vinpocetine alone （ 30 patients, control group ）. Both groups also received basic treatment. Results There was a significant difference between the study group and the control group in total effectiveness rate （ 100% vs. 70%, P〈 0.05 ） and the study group was superior to the control group in the efficacy. Conclusion Combination therapy with edaravone and vinpocetine can markedly increase the efficaey in the treatment of acute cerebral infarction. It is worth popularizing in clinical practice.